DURECT Corp (DRRX) Reports In-Line Q4 EPS

DURECT Corp (NASDAQ: DRRX) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.77 million.

For earnings history and earnings-related data on DURECT Corp (DRRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c